Telus Corporation Ordinary Shares (TU)

Total Costs & Expenses

$17.21B

TTM · Period ending: · CAD

TU logo

TU Total Costs & Expenses

Latest reported$17.21B CAD
TU TTM Total Costs & Expenses · CAD ($4.61B → $17.21B)
High-resolution chart · PNG

TU total costs & expenses history

Trailing twelve months (TTM) · CAD. Each value covers four complete reported quarters.

Telus Corporation Ordinary Shares Total Costs & Expenses — Trailing twelve months (TTM) (CAD)
Period endingTotal Costs & Expenses (CAD)
17,212,000,000
17,882,000,000
17,983,000,000
18,019,000,000
17,948,000,000
17,310,000,000
17,335,000,000
17,255,000,000
17,474,000,000
17,608,000,000
17,643,000,000
17,505,000,000
16,876,000,000
16,135,000,000
15,338,000,000
14,393,000,000
14,103,000,000
13,943,000,000
13,764,000,000
13,869,000,000
13,659,000,000
13,230,000,000
12,859,000,000
12,481,000,000
12,039,000,000
11,864,000,000
11,612,000,000
11,540,000,000
11,452,000,000
11,353,000,000
11,258,000,000
11,012,000,000
10,893,000,000
10,729,000,000
10,564,000,000
10,798,000,000
10,712,000,000
10,554,000,000
10,543,000,000
10,217,000,000
10,152,000,000
10,201,000,000
10,077,000,000
9,933,000,000
9,783,000,000
9,617,000,000
9,547,000,000
9,419,000,000
9,305,000,000
9,266,000,000
9,175,000,000
9,124,000,000
8,189,000,000
8,042,000,000
7,963,000,000
7,785,000,000
8,537,000,000
8,460,000,000
8,357,000,000
8,247,000,000
8,083,000,000
7,904,000,000
7,797,000,000
7,700,000,000
7,653,000,000
7,661,000,000
7,647,000,000
7,542,900,000
7,558,400,000
7,579,500,611
7,528,000,611
7,439,700,443
7,257,300,116
7,092,299,718
7,079,699,626
7,029,799,973
6,939,799,439
6,798,198,389
6,598,498,621
6,552,797,513
6,554,397,561
6,510,097,858
6,417,197,597
6,283,198,362
6,172,899,829
6,115,400,169
6,081,100,553
6,036,101,365
5,974,599,955
5,950,500,046
5,954,700,018
5,962,799,370
6,007,900,126
6,056,499,052
6,058,399,518
6,398,200,575
6,420,200,260
6,437,302,502
6,500,600,981
6,184,999,804
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.